Statement by Healthcare Leadership Council President Mary R. Grealy On House Introduction of Drug Pricing Legislation

April 22, 2021

The drug pricing legislation being introduced in the U.S. House of Representatives, HR 3, is a sledgehammer approach to achieving greater prescription drug affordability and it threatens to do severe … Continued

New Report on Public-Private Collaboration in Vaccine Distribution Provides Important Guidance in Combating COVID-19 Pandemic

April 12, 2021

Healthcare Leadership Council Praises Work of Duke-Margolis Center for Health Policy and the COVID Collaborative WASHINGTON – As federal and state policymakers continue to strive toward higher levels of COVID-19 … Continued